These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22516775)

  • 1. [Effects of elimination diets on bone metabolism in children and adolescents with phenylketonuria, galactosemia and celiac disease].
    Gajewska J; Ambroszkiewicz J; Chełchowska M; Laskowska-Klita T
    Med Wieku Rozwoj; 2012; 16(1):61-9. PubMed ID: 22516775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum markers of bone turnover in children and adolescents with classic galactosemia.
    Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
    Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism in galactosemia.
    Panis B; Forget PP; van Kroonenburgh MJ; Vermeer C; Menheere PP; Nieman FH; Rubio-Gozalbo ME
    Bone; 2004 Oct; 35(4):982-7. PubMed ID: 15454106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone health and multiple sclerosis.
    Dobson R; Ramagopalan S; Giovannoni G
    Mult Scler; 2012 Nov; 18(11):1522-8. PubMed ID: 22740489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone mineral turnover and bone densitometry in patients with dietary risk: hyperphenylalaninemia and galactosemia].
    Moreno Villares JM; Oliveros Leal L
    An Pediatr (Barc); 2006 Mar; 64(3):284; author reply 284-5. PubMed ID: 16527101
    [No Abstract]   [Full Text] [Related]  

  • 6. Dairy calcium, bone metabolism, and prevention of osteoporosis.
    Renner E
    J Dairy Sci; 1994 Dec; 77(12):3498-505. PubMed ID: 7699131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone mineral turnover and bone densitometry in patients with a high-risk diet: hyperphenylalaninemia and galactosemia].
    Fernández Espuelas C; Manjón Llorente G; González López JM; Ruiz-Echarri MP; Baldellou Vázquez A
    An Pediatr (Barc); 2005 Sep; 63(3):224-9. PubMed ID: 16219275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of bone formation and resorption in prepubertal children with phenylketonuria].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Med Wieku Rozwoj; 2003; 7(1):89-95. PubMed ID: 13130173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of bone mineral density in children with celiac disease].
    Krzesiek E; Iwańczak B
    Pol Merkur Lekarski; 2008 Mar; 24(141):219-26. PubMed ID: 18634287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic special diets.
    Francis DE
    Practitioner; 1974 Apr; 212(1270 Spec No):545-51. PubMed ID: 4417787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mineral content in bones of children with symptomless celiac disease and gluten-free diet].
    Szathmári M; Tulassay T; Arató A; Bodánszky H; Szabó A; Tulassay Z
    Orv Hetil; 1997 Dec; 138(51):3233-8. PubMed ID: 9454102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of bone turnover markers in prepubertal children with phenylketonuria.
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Eur J Pediatr; 2004 Mar; 163(3):177-8. PubMed ID: 14749925
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis.
    Turner J; Pellerin G; Mager D
    J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):589-93. PubMed ID: 19644400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone health as a primary target in the pediatric age.
    Caradonna P; Rigante D
    Eur Rev Med Pharmacol Sci; 2009; 13(2):117-28. PubMed ID: 19499847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of bone health in patients with celiac disease: Practical guide for clinicians.
    Duerksen D; Pinto-Sanchez MI; Anca A; Schnetzler J; Case S; Zelin J; Smallwood A; Turner J; Verdú E; Butzner JD; Rashid M
    Can Fam Physician; 2018 Jun; 64(6):433-438. PubMed ID: 29898932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations of bone metabolism in children and adolescents with diabetes mellitus type 1].
    Pater A; Odrowąż-Sypniewska G
    Pediatr Endocrinol Diabetes Metab; 2011; 17(3):158-61. PubMed ID: 22027070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach.
    Di Stefano M; Mengoli C; Bergonzi M; Corazza GR
    Nutrients; 2013 Nov; 5(11):4786-99. PubMed ID: 24284619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone metabolic disease associated with celiac disease].
    Bai JC; Mauriño EC
    Gastroenterol Hepatol; 1997 Apr; 20(4):209-16. PubMed ID: 9280617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in children with cancer.
    van der Sluis IM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):474-8; discussion 486. PubMed ID: 18064660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.